Stocks and Investing
by (remove) : Akash Tewari
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Akash Tewari
RSSJSONXMLCSV
Tue, September 17, 2024
Fri, September 13, 2024
Wed, August 28, 2024
Wed, July 31, 2024
Tue, April 9, 2024
Wed, March 6, 2024
Tue, March 5, 2024
Mon, February 5, 2024
Mon, December 11, 2023
Wed, December 6, 2023
Tue, November 28, 2023
Tue, August 8, 2023
Mon, July 17, 2023
Wed, June 7, 2023
Tue, May 30, 2023
Mon, March 6, 2023
Tue, December 20, 2022
Fri, December 16, 2022
Mon, December 12, 2022
Tue, November 29, 2022
Mon, October 10, 2022
Tue, June 21, 2022
Thu, October 7, 2021
Thu, February 22, 2018
Fri, July 29, 2016
Tue, March 10, 2015
Thu, January 31, 2013

Akash Tewari Upgraded (BNTX) to Strong Buy and Increased Target to $150 on, Sep 17th, 2024


Published on 2024-10-28 14:19:14 - WOPRAI, Akash Tewari
  Print publication without navigation


Akash Tewari of Jefferies, Upgraded "BioNTech SE" (BNTX) to Strong Buy and Increased Target from $96 to $150 on, Sep 17th, 2024.

Akash has made no other calls on BNTX in the last 4 months.



There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 2 agree with Akash's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jessica Fye of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $125 on, Monday, September 16th, 2024
  • Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $85 on, Tuesday, August 6th, 2024


These are the ratings of the 3 analyists that currently disagree with Akash


  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $113 on, Monday, September 16th, 2024
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $150 on, Monday, September 16th, 2024
  • Emmanuel Papadakis of "Deutsche Bank" Upgraded from Hold to Strong Buy and Held Target at $95 on, Wednesday, August 7th, 2024
Contributing Sources